aHypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic (IDIBAPS), University of Barcelona, Barcelona

bCIBER-OBN. ISCIII Madrid

cFaculty of Medicine, University of Barcelona, Spain

dDivision of cardiology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon

eCatholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea

fCardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12

gCIBER-CV, Hospital Universitario 12 de Octubre

hFaculty of Sport Sciences, European University of Madrid, Madrid, Spain

Correspondence to Miguel Camafort, MD, PhD, Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic University of Barcelona, Villarroel 170 08029 Barcelona, Spain. Tel: +34 932275400; e-mail: [email protected]